← Back to all trials
Completed
NCT04322370
Prospective Randomized Blinded Trial of VersaWrap Tendon Protector for Zone 2 Flexor Tendon Injuries
Conditions: Flexor Tendon
Sex: All
Ages: 18 Years – 99 Years
Healthy volunteers: No
Phase: NA
Enrollment: 11
Sponsor: University of Florida
Location: University of Florida Gainesville Florida
Summary
To analyze outcomes between patients with Z2FT injuries following repair, randomized to two groups. The first group will be the negative control, with no tendon wrap. The second group will have a VersaWrap Tendon Protector applied over the site of the tendon repair. VersaWrap is current SOC at UF.
Eligibility Criteria
Inclusion Criteria:
* Adult patients presenting to the plastic surgery service with a zone 2 flexor tendon injury requiring surgical repair
Exclusion Criteria:
* Patients with a sensitivity or allergy to polysaccharides alginate, hyaluronic acid, or citrate
* Patients with psychiatric or medical problems that preclude them from having surgery
* Female patients that are pregnant or breastfeeding
* Prisoners
* Patients who are unwilling or unable to follow-up
Source: ClinicalTrials.gov (NCT04322370). StuddyBuddy aggregates publicly available trial information.